QA: AVEO Pharmaceuticals INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001325879_2022_AVEO_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001325879, AVEO Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 104,736,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 276,000
3 remainder_Assets 329,000
4 LiabilitiesCurrent 18,731,000
5 LiabilitiesNoncurrent 2,780,000
6 remainder_Liabilities 37,960,000
7 CostOfGoodsAndServicesSold 4,737,000
8 SellingGeneralAndAdministrativeExpense 112,169,458
9 ResearchAndDevelopmentExpense 26,412,988
10 remainder_Expenses 0
11 remainder_Revenues 30,619,523
12 remainder_NetIncome -983,433
13 remainder_ComprehensiveNetIncome -2,052
  yvar yval
0 Assets 105,341,000
1 Liabilities 59,471,000
2 Expenses 143,319,446
3 Revenues 30,619,523
4 StockholdersEquity 45,870,000
5 NetIncome -113,683,356
6 ComprehensiveNetIncome -113,684,382
7 BaseVar 169,868,227
8 EconomicCapitalRatiobeforeLimitedLiability -0.166
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time